News und Analysen

Shares of health insurer UnitedHealth Group (NYSE: UNH) received a boost last week after investors learned that Warren Buffett's company, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), has invested

What the stock analysis community giveth, it can also taketh away.

That was the dynamic behind the slide of UnitedHealth Group (NYSE: UNH) stock on Tuesday. As in the previous trading session, the

Medtronic (NYSE: MDT) stock had declined 3.6% through 2:45 p.m. ET Tuesday despite beating forecasts for fiscal 2026 first-quarter earnings this morning.

Heading into the report, analysts predicted

Medtronic (NYSE:MDT), a global medical technology leader specializing in cardiovascular, neuroscience, and surgical devices, reported Q1 FY2026 earnings on August 19, 2025. The most notable news

UnitedHealth Group (NYSE: UNH) has been a staple in the healthcare world for decades and is one of the largest companies in the world, with a market cap of around $280 billion as of Aug. 18

Finding a high-yielding stock that is safe to hang on to can be a rarity. When yields get high (e.g., more than 5%), usually there's a reason behind it. And investors are often hesitant to invest in

UnitedHealth Group (NYSE: UNH), by far the health insurance stock that's gotten most of the market's attention over the past few trading sessions, had a good Monday on the exchange. Its shares added

AbbVie (NYSE: ABBV) became a stand-alone, publicly traded company when it split from its former parent, Abbott Laboratories, in 2013. The reason for the split was for each company to generate

Over the past few years, the market hasn't been kind to somewhat speculative, unprofitable stocks. CRISPR Therapeutics (NASDAQ: CRSP), a mid-cap biotech, fits that description. The company's shares

Dividend stocks are a great investment choice for many reasons. Buying on the dip is even better, provided, of course, they have the means to bounce back.

Investors looking for companies that fit

Even well-established drugmakers can lose significant market value overnight following a setback. That's what recently happened to Vertex Pharmaceuticals (NASDAQ: VRTX). The company's shares fell by

Pfizer (NYSE: PFE) was a hot stock during the pandemic, but it has been crashing in recent years. The company's COVID vaccine resulted in the business posting record sales and profits in 2022. But

UnitedHealth Group (NYSE: UNH) has been a solid dividend growth stock for years. Generally, its yield has been fairly low, due to the stock's rising value. Even as the healthcare insurance giant has

The market has abandoned UnitedHealth Group (NYSE: UNH), and that's exactly why I'm buying it. While investors flee the stock over rising medical costs and regulatory headlines, they're missing a

Medtronic (NYSE: MDT) isn't getting much love on Wall Street today. The stock has fallen around 33% since hitting a peak in mid-2021. That's a huge decline, but it may be overdone. Sure, there are

Novo Nordisk (NYSE: NVO) and UnitedHealth (NYSE: UNH) have seen their share prices fall in recent weeks.

*Stock prices used were the afternoon prices of Aug. 11, 2025. The video was published on

People have sung Fleetwood Mac's lyrics for decades: "Don't stop thinking about tomorrow." But investors might want to focus on a different timeline.

No one knows what tomorrow holds. At least with

UnitedHealth (NYSE: UNH) stock was proving to be beneficial for investors' financial health on Hump Day. They were trading the big health insurance company's stock up by nearly 4% in late-session

Many income investors probably have mixed emotions about stocks with ultra-high dividend yields. On one hand, they love the tremendous income these stocks provide. On the other hand, they might

Wondering how well you'd have done if you'd invested in pharmaceutical giant Pfizer (NYSE: PFE) three years ago and hung on? Well, I'm afraid the answer isn't pretty: If you'd investing $1,000 in

Pfizer (NYSE: PFE) has been a terrible investment over the past three years. Revenue and earnings have generally moved in the wrong direction, as the company has been unable to follow up on the

Ah, 10 years ago. It was 2015, and selfie sticks and hoverboards were all over. Apple debuted its Apple Watch to much fanfare, and...perhaps you invested in shares of Zoetis (NYSE: ZTS) stock? If

AppLovin (NASDAQ: APP) once again held up to the short-seller scrutiny it's been under, with yet another quarter of surging revenue and profitability growth. The stock is now up more than 500% over

It's been a tough stretch for pharmaceutical giant Pfizer (NYSE: PFE). The company enjoyed a vaccine windfall during the COVID-19 pandemic, but revenue and profits cratered as the pandemic eased and

Priorities change as you enter new seasons of life. That's especially true for your retirement years. And the changing priorities can include what you want from your investments. Income usually